Wow – these are the AI sources worth paying attention to
Isomorphic Labs has raised $2.1 billion to advance AI-driven drug discovery, building on AlphaFold's protein structure prediction breakthroughs. Researchers have developed an AI model capable of solving Olympiad-level math and science problems using advanced training techniques. OpenAI has integrated Codex into ChatGPT, enabling remote Mac control from iPhones and consolidating its product teams under a unified strategy.
- ▪Isomorphic Labs, founded by Demis Hassabis, raised $2.1 billion to accelerate AI-based drug discovery using AlphaFold technology.
- ▪A new AI model trained with reverse perplexity curriculum and reinforcement learning achieved gold-medal performance in international math and physics Olympiads.
- ▪OpenAI integrated Codex into the ChatGPT app, allowing users to remotely control Mac devices from their iPhones.
- ▪X platform open-sourced its 'For You' recommendation algorithm on GitHub, promoting transparency in social media ranking systems.
- ▪OpenAI merged ChatGPT, Codex, and its developer API into a single product team led by Greg Brockman to unify its consumer and developer offerings.
Hacker News (AI / LLM) files mainly under ai. We currently carry 2,519 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Fav0 |
| Canonical URL | https://fav0.com/en/2026-05-16/ |
| Publication time | Sat, 16 May 2026 14:46:29 +0000 |
| Retrieval time | 2026-05-16T15:00:18.835Z |
| Last seen | 2026-05-16T15:00:18.835Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | dtIwzR6M9I2d |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
☰ FAV0 May 16, 2026 · Saturday Isomorphic Labs raises $2.1B to accelerate AI drug discovery Google DeepMind co-founder Demis Hassabis founded Isomorphic Labs completes $2.1 billion funding round for AI protein structure prediction and molecular design. Isomorphic Labs builds on AlphaFold breakthroughs to design novel molecules and shorten drug development timelines. Isomorphic Labs, the AI-first drug discovery company founded by Google DeepMind co-founder Demis Hassabis, has raised $2.1 billion in new funding. The company builds on DeepMind's groundbreaking AlphaFold protein structure prediction technology to design novel therapeutic molecules and dramatically shorten the drug development timeline.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Fav0.
Discussion
0 commentsMore from Fav0
